Trial
NCT04349280
A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
Merck KGaA, Darmstadt, Germany
Condition
Neoplasms
Intervention
Bintrafusp alfa
Why stopped
Primary investigator withdrew the participant due to an SAE
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-18